Search

Search Results

Results 3031 - 3040 of 8666 for Skin Cancer

Antiretroviral therapy may prevent excess risk of some cancers in people with HIV

News - 18 May 2005

In people infected with human immunodeficiency virus (HIV), highly active anti-retroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new...
Peplin has U.S. patent granted for novel anti-cancer compounds

News - 5 Apr 2005

Australian biotech Peplin Limited has announced today that the US Patent and Trademark Office had granted Peplin a patent covering the use of its macrocyclic anti-cancer compounds to stimulate the...
Early hormone therapy for metastatic prostate cancer increases life expectancy

News - 10 Jun 2004

Men with aggressive, metastatic prostate cancer who receive immediate early hormone therapy live on average three to four years longer than others who delay similar treatment, according to researchers...
Bavencio

Drug - 18 Sep 2026

Consumer Medicine Information (CMI) about Bavencio intended for persons living in Australia.
Duodart

Drug - 26 May 2026

Consumer Medicine Information (CMI) about Duodart intended for persons living in Australia.
Doubluts

Drug - 26 May 2026

Consumer Medicine Information (CMI) about Doubluts intended for persons living in Australia.
Imanib

Drug - 21 Apr 2026

Consumer Medicine Information (CMI) about Imanib intended for persons living in Australia.
Caprelsa

Drug - 10 Apr 2026

Consumer Medicine Information (CMI) about Caprelsa intended for persons living in Australia.
Eprex

Drug - 4 Mar 2026

Consumer Medicine Information (CMI) about Eprex intended for persons living in Australia.
Rinvoq

Drug - 21 Jan 2026

Consumer Medicine Information (CMI) about Rinvoq intended for persons living in Australia.

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.